Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench; on behalf of the Australian Ovarian Cancer Study, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich
Lara E. Sucheston-Campbell
1College of Pharmacy, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rikki Cannioto
2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyssa I. Clay
3Cancer Genetic Epidemiology, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Lewis Etter
2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin H. Eng
4Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Song Liu
4Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastiano Battaglia
5Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiang Hu
4Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Brian Szender
6Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albina Minlikeeva
2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janine M. Joseph
2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Mayor
6Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott I. Abrams
7Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brahm H. Segal
7Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.
8Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul K. Wallace
9Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kah Teong Soh
9Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emese Zsiros
6Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hoda Anton-Culver
10Genetic Epidemiology Research Institute, School of Medicine, University of California Irvine, Irvine, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa V. Bandera
11Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias W. Beckmann
12Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Berchuck
13Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Line Bjorge
14Department of Gynecology and Obstetrics, Haukeland University Horpital, Bergen, Norway.
15Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Bruegl
16Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian G. Campbell
17Cancer Genetics Laboratory, East Melbourne, Australia.
18Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shawn Patrice Campbell
16Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Chenevix-Trench
19Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel W. Cramer
20Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.
21Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnieszka Dansonka-Mieszkowska
22Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanny Dao
23Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Diergaarde
24Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thilo Doerk
25Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer A. Doherty
26Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas du Bois
27Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
28Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Eccles
29Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
30Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Southampton, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Svend Aage Engelholm
31Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A. Fasching
12Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon A. Gayther
32Center for Cancer Prevention and Translational Genomics, Cedars-Sinai Medical Center, Los Angeles, California.
33Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandra Gentry-Maharaj
34Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalind M. Glasspool
35The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc T. Goodman
36Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
37Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacek Gronwald
38Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Harter
27Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Hein
12Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Heitz
27Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
28Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hillemmanns
25Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claus Høgdall
39Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Estrid V.S. Høgdall
40Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
41Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomasz Huzarski
38Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Jensen
40Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon E. Johnatty
19Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Jung
42Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
43University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth Y. Karlan
44Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reudiger Klapdor
25Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomasz Kluz
45Clinic of Obstetrics and Gynecology, Institute of Midwifery and Emergency Medicine, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bożena Konopka
22Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Krüger Kjær
39Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark.
40Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jolanta Kupryjanczyk
22Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diether Lambrechts
46Department of Oncology, Laboratory for Translational Genetics, Vesalius Research Center, University of Leuven, Leuven, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny Lester
44Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Lubiński
38Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas A. Levine
23Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lene Lundvall
47Department of Gynecology, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie McGuire
48Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain A. McNeish
49Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Usha Menon
34Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesmary Modugno
24Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
50Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
51Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberta B. Ness
52The University of Texas School of Public Health, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Orsulic
44Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Paul
35The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celeste Leigh Pearce
53Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
54Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanja Pejovic
16Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
55Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Pharoah
56Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
57Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan J. Ramus
58School of Women's and Children's Health, University of New South Wales, New South Wales, Australia.
59The Kinghorn Cancer Centre, Garvan Institute of Medical Research, New South Wales, New South Wales, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Rothstein
48Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Anne Rossing
60Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
61Department of Epidemiology, University of Washington, Seattle, Washington.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Rübner
12Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joellen M. Schildkraut
62Department of Public Health Sciences, The University of Virginia, Charlottesville, Virginia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Schmalfeldt
63Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ira Schwaab
64Praxis für Humangenetik, Wiesbaden, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadeem Siddiqui
65Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiva Sieh
66Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
67Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piotr Sobiczewski
68Department of Gynecologic Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Honglin Song
56Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn L. Terry
20Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.
21Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Els Van Nieuwenhuysen
69Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriaan Vanderstichele
69Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignace Vergote
69Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine S. Walsh
44Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penelope M. Webb
70Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Wentzensen
71Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice S. Whittemore
48Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna H. Wu
54Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Argyrios Ziogas
72Department of Epidemiology, University of California Irvine, Irvine, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kunle Odunsi
6Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny Chang-Claude
42Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
43University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen L. Goode
73Department of Health Science Research, Mayo Clinic, Rochester, Minnesota.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten B. Moysich
2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kirsten.moysich@roswellpark.org
DOI: 10.1158/1055-9965.EPI-16-0631 Published March 2017
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    These five concentric circles are circular standard Manhattan plots. The chromosome is on the outer circle, −log10 P values are on the y-axis (vertical), with each circle representing the P value from single SNP tests of association with overall survival adjusted for age, stage, and grade. A–E, The Manhattan plots are as follows: all ovarian cancer cases (A); high-grade serous (B); mucinous cell (C); endometrioid (D); and clear cell (E). The red dashed line designates P = 0.01, −log10(P value) = 2, with all red-colored SNPs above that line reflecting SNPs P < 0.01.

Tables

  • Figures
  • Table 1.

    Clinical characteristics of invasive EOC cases from the Ovarian Cancer Association Consortium analyzed for association with MSDC genetic variation

    Vital status at last follow-up
    Patient characteristicsAliveDeceasedTotal invasive EOC cases
    n = 5,243 (48.8%)n = 5,508 (51.2%)N = 10,751
    Age at diagnosis
     <50 years1,627 (59.1%)1,125 (40.9%)2,752
     50–69 years3,100 (47.4%)3,445 (52.6%)6,545
     70+ years516 (35.5%)938 (64.5%)1,454
    Histology
     Serous2,765 (39.7%)4,207 (60.3%)6,972
     High-grade serous2,210 (38.2%)3,568 (61.8%)5,578
     Mucinous504 (72.1%)197 (27.9%)701
     Endometrioid1,058 (68.7%)485 (31.3%)1,543
     Clear cell529 (67.1%)260 (32.9%)789
     Mixed cell215 (56.7%)166 (43.3%)381
     Undifferentiated/poorly differentiated92 (42.6%)124 (57.4%)216
     Unknown epithelial70 (49.6%)69 (50.3%)139
    Grade
     Well differentiated757 (70.5%)316 (29.3%)1,073
     Moderately differentiated1,107 (50.6%)1,079 (49.4%)2,186
     Poorly differentiated2,185 (42.4%)2,969 (57.6%)5,154
     Undifferentiated284 (46.8%)323 (53.2%)607
     Unknown583 (58.1%)419 (41.9%)1,002
    Stage
     Localized1,393 (81.3%)320 (18.7%)1,713
     Regional1,314 (66.4%)665 (33.6%)1,979
     Distant2,109 (34.3%)4,034 (65.7%)6,134
     Unknown178 (55.5%)143 (44.5%)321
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 26 (3)
March 2017
Volume 26, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich on behalf of the Australian Ovarian Cancer Study
Cancer Epidemiol Biomarkers Prev March 1 2017 (26) (3) 420-424; DOI: 10.1158/1055-9965.EPI-16-0631

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich on behalf of the Australian Ovarian Cancer Study
Cancer Epidemiol Biomarkers Prev March 1 2017 (26) (3) 420-424; DOI: 10.1158/1055-9965.EPI-16-0631
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Associations of ACEi and ARB with CRC risk
  • PDE5 Inhibitor Use and Precursors of Colorectal Cancer
  • Association Between Serum Iron Biomarkers and Breast Cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement